- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03773705
Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery
Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery: A Single-blinded Randomized Controlled Trial
Pituitary tumours have an estimated prevalence of 20% in the general population and the number of clinically relevant pituitary adenomas is increasing with time. When symptomatic, the standard of care required for pituitary adenomas is resection through an endoscopic transsphenoidal approach. There is however significant olfactory dysfunction following endoscopic transsphenoidal pituitary surgery with approximately 23% of patients reporting some degree of worsening in their sense of smell in the postoperative period.
Pedicled nasoseptal flaps are used to repair skull base defects following resection of skull base tumours. The superior incision is placed in close proximity to olfactory mucosa. Currently, these flaps are raised either with the use of electrocautery or scalpel. The use of electrocautery in surgery has provided surgeons with greater hemostasis when compared to a scalpel. This is of utmost importance in many regions of the head & neck where highly vascularized tissue results in difficulties achieving adequate hemostasis and therefore limiting view of the surgical field. However, the use of electrocautery increases thermal damage to surrounding tissue and impairs wound healing when compared to a scalpel.
Although the transmission of thermal energy via electrocautery to adjacent mucosa containing olfactory epithelium may theoretically contribute to olfactory disturbances, no prospective randomized controlled trials have yet examined the impact of these two different techniques on postoperative olfactory function. The purpose of this research study is to determine the effects, if any, of electrocautery versus scalpel on olfaction in raising the nasoseptal flap for repairing skull base defects following transphenoidal surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pedicled nasoseptal flaps are used to repair skull base defects following endoscopic transphenoidal surgery. The superior incision is placed in close proximity to olfactory mucosa. Currently, these flaps are raised either with the use of electrocautery or scalpel. While it is hypothesized that the olfactory mucosa is at greater risk of thermal injury with the use of electrocautery, no prospective multi-center studies have examined the impact of these two different techniques on postoperative olfactory function.
Patients will be recruited through the Otolaryngology-Head & Neck Surgery clinics. Based on previous studies in a North American population, a 10% change in UPSIT score was considered to be significant. With an alpha error set to 0.05, a beta of 0.8 and an effect size of 1 standard deviation, a sample size of 20 was calculated.
After obtaining consent for enrolment into the study, each patient will undergo either: (1) electrocautery or (2) scalpel in the elevation of nasoseptal flaps based on primary surgeon preference. The University of Pennsylvania Smell Identification Test (UPSIT) will be used for baseline testing of olfactory function in all enrolled patients. Postoperatively, all enrolled patients will be seen in follow-up at 1, 3 and 6 months' time, at which point the UPSIT will be administered for testing of postoperative olfactory function.
The Wilcoxon signed-rank test will be used to determine differences between UPSIT scores pre- and postoperatively. Results of p<0.05 will be considered statistically significant. Linear regression will be used to examine relationships between UPSIT scores and other variables collected (e.g., demographic data, size/type of pituitary tumour, length of nasoseptal flap).
Given that approximately 23% of all patients who undergo endoscopic transphenoidal surgery note some degree of worsening in their sense of smell following surgery, a prospective multi-center study comparing the two techniques would provide impetus to pursue one strategy over another in order to maintain an important sense, olfaction. Through optimizing preservation of olfactory mucosa during endoscopic skull base surgeries, patients' likelihood of not detecting environmental hazards (e.g., smoke, gas, other poisonous materials) will be reduced and, equally as important, their quality of life would be improved.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: John Lee, MD
- Phone Number: 416-864-5306
- Email: leejo@smh.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1W8
- Recruiting
- St. Michael's Hospital
-
Contact:
- Andrea Figol, MSc
- Phone Number: 6591 416-864-6060
- Email: FigolA@smh.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients (age ≥18 years)
- Patients with tumours of the pituitary gland electively scheduled for endoscopic transsphenoidal surgery with nasoseptal flap coverage
Exclusion Criteria:
- Documented evidence of sinonasal disease on either nasal endoscopy or radiography
- Patients with a clinical history of asthma and/or sinonasal disease
- Previous sinus surgery
- Previous skull base surgery
- History of pre-existing hyposmia or anosmia
- Use of medication(s) known to alter sense of smell at time of test
- UPSIT scores <5 indicating a functional component to alteration in olfaction
- Development of postoperative cerebrospinal fluid leak necessitating re-entry into the operative field containing the nasoseptal flap
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Electrocautery group
Electrocautery used to raise pediclued nasoseptal flaps to repair skull based defects following endoscopic transphenoidal surgery.
|
Electrocautery versus scalpel in the elevation of nasoseptal flaps following endoscopic transsphenoidal pituitary surgery
|
Active Comparator: Scalpel group
Scalpel used to raise pediclued nasoseptal flaps to repair skull based defects following endoscopic transphenoidal surgery.
|
Electrocautery versus scalpel in the elevation of nasoseptal flaps following endoscopic transsphenoidal pituitary surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in University of Pennsylvania Smell Identification Test (UPSIT)
Time Frame: Initial visit and at 1, 3 and 6-month follow-up visits
|
Standardized and validated test of olfaction, which uses microencapsulated odorants released by scratching test booklets.
Participants are asked to fill out forced choice multiple alternative questionnaires regarding each odorant.
Minimum total score 0, maximum total score 40.
Higher scores represent a better outcome.
|
Initial visit and at 1, 3 and 6-month follow-up visits
|
Change in Sniffin' Sticks
Time Frame: Initial visit and at 1, 3 and 6-month follow-up visits
|
Validated 16-item odor identification test.
Minimum total score 0, maximum total score 16.
Higher scores represent better outcome.
|
Initial visit and at 1, 3 and 6-month follow-up visits
|
Change in Sino-Nasal Outcome Test-22 (SNOT-22)
Time Frame: Initial visit and at 1, 3 and 6-month follow-up visits
|
Disease-specific, quality-of-life related measure of sinonasal function.
Test consists of 22 symptoms requiring responders to rate severity on a 5-point Likert scale 0-5.
Minimum score 0, maximum score 110.
Higher scores correlate with greater rhinosinusitus-related health burden.
|
Initial visit and at 1, 3 and 6-month follow-up visits
|
Change in Skull Base Inventory (SBI)
Time Frame: Initial visit and at 1, 3 and 6-month follow-up visits
|
Multidimensional, disease-specific instrument designed to measure quality of life of patients who undergo surgical treatment for anterior or central skull base pathologies.
It covers several disease-specific domains including cognitive, endocrine, nasal, neurologic, visual, and other general areas.Each item is weighted equally in each domain score.
Each domain is weighted equally in the overall score.
Domain scores are calculated by taking the total score (sum of all items) in that domain divided by the maximum possible score for that domain multiplied by 100.
The minimum score for each domain is 0 and the maximum is 100.
The minimum score for the questionnaire is 0 and the maximum is 100.
Higher score indicates better outcomes.
|
Initial visit and at 1, 3 and 6-month follow-up visits
|
Change in Pre-Op and Post-Op Endoscopy Scores
Time Frame: Initial visit and at 1, 3 and 6-month follow-up visits
|
Used to quantify the pathological states of the nose and paranasal sinuses.
Calculated on left and right side out, minimum 0, maximum 14.
Higher scores indicate objectively worse sinonasal inflammation.
|
Initial visit and at 1, 3 and 6-month follow-up visits
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John Lee, MD, Unity Health Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms
- Neoplasms by Site
- Wounds and Injuries
- Endocrine System Diseases
- Endocrine Gland Neoplasms
- Craniocerebral Trauma
- Trauma, Nervous System
- Hypothalamic Diseases
- Hypothalamic Neoplasms
- Supratentorial Neoplasms
- Brain Neoplasms
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Cranial Nerve Diseases
- Olfactory Nerve Diseases
- Cranial Nerve Injuries
- Pituitary Neoplasms
- Pituitary Diseases
- Olfactory Nerve Injuries
Other Study ID Numbers
- 17-301
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
-
EgymedicalpediaCompletedSurgery | Pediatric SurgeryEgypt
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
Clinical Trials on Electrocautery versus scalpel
-
Dartmouth-Hitchcock Medical CenterEthicon Endo-SurgeryTerminated
-
Dr. Sam M. WisemanRecruiting
-
Turku University HospitalTerminated
-
St. Paul's Hospital, CanadaCompletedSurgical Wound Infection | Post-operative Pain | Wound ComplicationCanada
-
Sentara Cardiovascular Research InstituteEthicon Endo-SurgeryRecruiting
-
Karolinska InstitutetRecruitingUltrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis TrialCholecystitis, AcuteSweden
-
West China HospitalUnknownQuality of Life | Gastric Cancer | Surgery | Blood Loss, Surgical | External Causes of Morbidity and Mortality | Ultrasonic Scalpel | Monopolar Electrocautery | Operation TimeChina
-
Saint Thomas Hospital, PanamaCompletedSurgical Wound InfectionPanama
-
Royal Infirmary of EdinburghUnknownOsteo Arthritis Knee | Arthroplasty, Replacement, KneeUnited Kingdom
-
University of British ColumbiaNot yet recruitingPostoperative Complications | Surgical Wound Infection | Scar | Post-operative Pain | Wound ComplicationCanada